Sire Group Ltd. - Sep 13, 2023 Form 3 Insider Report for TITAN PHARMACEUTICALS INC (TTNP)

Role
10%+ Owner
Signature
THE SIRE GROUP LTD, By: /s/ Seow Gim Shen, Chief Executive Officer
Stock symbol
TTNP
Transactions as of
Sep 13, 2023
Transactions value $
$0
Form type
3
Date filed
10/4/2023, 04:40 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TTNP Common Stock 20.8M Sep 13, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TTNP Series AA Convertible Preferred Stock ("Preferred Stock") Sep 13, 2023 Common Stock 20.8M $0.47 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The total number of shares into which the Preferred Stock ultimately is convertible is as set forth in the table, but the Preferred Stock contains restrictions limiting the number of converted shares that the reporting persons may have at any one time, without Issuer stockholder approval, to 3,001,757 shares.
F2 Seow Gim Shen owns the shares beneficial ownership is indirect, by virtue of his sole ownership of The Sire Group Ltd., which owns the shares directly.
F3 Not Applicable